--- title: "CoreWeave's third-quarter revenue was $1.36 billion, while analysts expected $1.29 billion. The net loss for the third quarter was $110.1 million, compared to an expected loss of $299.6 million" type: "News" locale: "en" url: "https://longbridge.com/en/news/265212206.md" description: "CoreWeave achieved revenue of $1.36 billion in the third quarter, exceeding analysts' expectations of $1.29 billion. Meanwhile, the net loss was $110.1 million, lower than the expected $299.6 million" datetime: "2025-11-10T21:10:46.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/265212206.md) - [en](https://longbridge.com/en/news/265212206.md) - [zh-HK](https://longbridge.com/zh-HK/news/265212206.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/265212206.md) | [繁體中文](https://longbridge.com/zh-HK/news/265212206.md) # CoreWeave's third-quarter revenue was $1.36 billion, while analysts expected $1.29 billion. The net loss for the third quarter was $110.1 million, compared to an expected loss of $299.6 million CoreWeave's revenue in the third quarter was $1.36 billion, while analysts expected $1.29 billion. The net loss in the third quarter was $110.1 million, with an expected loss of $299.6 million. Risk Warning and Disclaimer The market has risks, and investment should be cautious. This article does not constitute personal investment advice and does not take into account the specific investment objectives, financial situation, or needs of individual users. Users should consider whether any opinions, views, or conclusions in this article are suitable for their specific circumstances. Investment based on this is at one's own risk ### Related Stocks - [CoreWeave, Inc. (CRWV.US)](https://longbridge.com/en/quote/CRWV.US.md) ## Related News & Research - [12 tons of KitKats vanished in a European highway heist](https://longbridge.com/en/news/280951958.md) - [12:03 ETTreeline Raises $25 Million to Reinvent IT Services](https://longbridge.com/en/news/281216608.md) - [Jefferies Adjusts Meitu's Price Target to HK$7 From HK$12.50, Keeps at Buy](https://longbridge.com/en/news/280991227.md) - [Macquarie Keeps Their Buy Rating on Elevra Lithium (SYAXF)](https://longbridge.com/en/news/280926326.md) - [16:12 ETIntensity Therapeutics Reports 2025 Year End Financial Results and Highlights, and Provides Corporate Update](https://longbridge.com/en/news/280841304.md)